PSY14 COST-EFFECTIVENESS AND BUDGET IMPACT OF LOW DOSE 7-DAY BUPRENORPHINE PATCH FOR MODERATE TO SEVERE OSTEOARTHRITIS PAIN IN THE CONTEXT OF KOREA NATIONAL HEALTH INSURANCE